{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:59:49Z","timestamp":1790891989138,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00292-017-0389-3","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T11:41:54Z","timestamp":1508154114000},"page":"491-499","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Okul\u00e4re Melanome","Ocular melanomas"],"prefix":"10.1007","volume":"38","author":[{"given":"H.","family":"Kalirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jaehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. E.","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,16]]},"reference":[{"issue":"2","key":"389_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/eye.2011.272","volume":"26","author":"BE Damato","year":"2012","unstructured":"Damato BE, Coupland SE (2012) Differences in uveal melanomas between men and women from the British Isle. Eye (Lond) 26(2):292. \n                        https:\/\/doi.org\/10.1038\/eye.2011.272","journal-title":"Eye (Lond)"},{"key":"389_CR2","first-page":"1","volume":"21","author":"R Caines","year":"2015","unstructured":"Caines R, Eleuteri A, Kalirai H, Fisher AC, Heimann H, Damato BE, Coupland SE, Taktak AF (2015) Cluster analysis of multiplex ligation-dependent probe amplification data in choroidal melanoma. Mol Vis 21:1\u201311","journal-title":"Mol Vis"},{"issue":"2","key":"389_CR3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/PPO.0b013e31824bd256","volume":"18","author":"SE Woodman","year":"2012","unstructured":"Woodman SE (2012) Metastatic uveal melanoma: biology and emerging treatments. Cancer\u00a0J 18(2):148\u2013152","journal-title":"Cancer J"},{"issue":"10","key":"389_CR4","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ophtha.2007.06.012","volume":"114","author":"B Damato","year":"2007","unstructured":"Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P (2007) Cytogenetics of uveal melanoma: a\u00a07-year clinical experience. Ophthalmology 114(10):1925\u20131931","journal-title":"Ophthalmology"},{"issue":"5","key":"389_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.preteyeres.2011.05.003","volume":"30","author":"B Damato","year":"2011","unstructured":"Damato B, Eleuteri A, Taktak AF, Coupland SE (2011) Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res 30(5):285\u2013295","journal-title":"Prog Retin Eye Res"},{"issue":"8","key":"389_CR6","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.1167\/iovs.14-14394","volume":"55","author":"T Jehs","year":"2014","unstructured":"Jehs T, Faber C, Juel HB, Bronkhorst IH, Jager MJ, Nissen MH (2014) Inflammation-induced chemokine expression in uveal melanoma cell lines stimulates monocyte chemotaxis. Invest Ophthalmol Vis Sci 55(8):5169\u20135175","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9010","key":"389_CR7","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","volume":"347","author":"G Prescher","year":"1996","unstructured":"Prescher G, Bornfeld N, Hirche H, Horsthemke B, Jockel KH, Becher R (1996) Prognostic implications of monosomy 3 in uveal melanoma. Lancet 347(9010):1222\u20131225","journal-title":"Lancet"},{"issue":"3","key":"389_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/gcc.2870050304","volume":"5","author":"K Sisley","year":"1992","unstructured":"Sisley K, Cottam DW, Rennie IG, Parsons MA, Potter AM, Potter CW, Rees RC (1992) Non-random abnormalities of chromosomes 3, 6, and 8 associated with posterior uveal melanoma. Genes Chromosomes Cancer 5(3):197\u2013200","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"389_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.0.CO;2-R","volume":"83","author":"VA White","year":"1998","unstructured":"White VA, Chambers JD, Courtright PD, Chang WY, Horsman DE (1998) Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83(2):354\u2013359","journal-title":"Cancer"},{"issue":"8","key":"389_CR10","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.5858\/2010-0477-OAR1","volume":"135","author":"IH Bronkhorst","year":"2011","unstructured":"Bronkhorst IH, Maat W, Jordanova ES, Kroes WG, Schalij-Delfos NE, Luyten GP, Jager MJ (2011) Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Pathol Lab Med 135(8):1042\u20131047","journal-title":"Arch Pathol Lab Med"},{"issue":"24","key":"389_CR11","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","volume":"16","author":"BE Damato","year":"2010","unstructured":"Damato BE, Dopierala JA, Coupland SE (2010) Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res 16(24):6083\u20136092","journal-title":"Clin Cancer Res"},{"issue":"2","key":"389_CR12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/eye.2012.255","volume":"27","author":"SE Coupland","year":"2013","unstructured":"Coupland SE, Lake SL, Zeschnigk M, Damato BE (2013) Molecular pathology of uveal melanoma. Eye (Lond) 27(2):230\u2013242","journal-title":"Eye (Lond)"},{"issue":"10","key":"389_CR13","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bjophthalmol-2015-307057","volume":"99","author":"SE Coupland","year":"2015","unstructured":"Coupland SE, Kalirai H, Ho V, Thornton S, Damato BE, Heimann H (2015) Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens. Br J Ophthalmol 99(10):1444\u20131450","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"389_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1504\/IJBET.2012.045355","volume":"8","author":"A Eleuteri","year":"2012","unstructured":"Eleuteri A, Damato B, Coupland SE, Taktak A (2012) Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic, clinical and genetic predictors of metastasis. Int J Biomed Eng Technol 8(1):18\u201335","journal-title":"Int J Biomed Eng Technol"},{"issue":"14","key":"389_CR15","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1167\/iovs.16-19654","volume":"57","author":"SW DeParis","year":"2016","unstructured":"DeParis SW, Taktak A, Eleuteri A, Enanoria W, Heimann H, Coupland SE, Damato B (2016) External validation of the liverpool uveal melanoma prognosticator online. Invest Ophthalmol Vis Sci 57(14):6116\u20136122","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"20","key":"389_CR16","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken MD, Worley LA, Ehlers JP, Harbour JW (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64(20):7205\u20137209","journal-title":"Cancer Res"},{"issue":"10","key":"389_CR17","first-page":"2578","volume":"63","author":"F Tschentscher","year":"2003","unstructured":"Tschentscher F, Husing J, Holter T, Kruse E, Dresen IG, Jockel KH, Anastassiou G, Schilling H, Bornfeld N, Horsthemke B, Lohmann DR, Zeschnigk M (2003) Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res 63(10):2578\u20132584","journal-title":"Cancer Res"},{"issue":"3","key":"389_CR18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e3283005270","volume":"18","author":"SH Chang","year":"2008","unstructured":"Chang SH, Worley LA, Onken MD, Harbour JW (2008) Prognostic biomarkers in uveal melanoma: evidence for a\u00a0stem cell-like phenotype associated with metastasis. Melanoma Res 18(3):191\u2013200","journal-title":"Melanoma Res"},{"issue":"8","key":"389_CR19","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ophtha.2012.02.017","volume":"119","author":"MD Onken","year":"2012","unstructured":"Onken MD, Worley LA, Char DH, Augsburger JJ, Correa ZM, Nudleman E, Aaberg TM Jr., Altaweel MM, Bardenstein DS, Finger PT, Gallie BL, Harocopos GJ, Hovland PG, McGowan HD, Milman T, Mruthyunjaya P et al (2012) Collaborative Ocular Oncology Group report number 1: prospective validation of a\u00a0multi-gene prognostic assay in uveal melanoma. Ophthalmology 119(8):1596\u20131603","journal-title":"Ophthalmology"},{"issue":"7","key":"389_CR20","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.ophtha.2013.03.036","volume":"120","author":"SE Coupland","year":"2013","unstructured":"Coupland SE, Damato BE (2013) Molecular analysis of uveal melanoma. Ophthalmology 120(7):e50","journal-title":"Ophthalmology"},{"issue":"3","key":"389_CR21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ajpath.2012.11.036","volume":"182","author":"SL Lake","year":"2013","unstructured":"Lake SL, Damato BE, Kalirai H, Dodson AR, Taktak AF, Lloyd BH, Coupland SE (2013) Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival. Am J Pathol 182(3):678\u2013687","journal-title":"Am J Pathol"},{"issue":"3","key":"389_CR22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/ICU.0000000000000051","volume":"25","author":"MG Field","year":"2014","unstructured":"Field MG, Harbour JW (2014) Recent developments in prognostic and predictive testing in uveal melanoma. Curr Opin Ophthalmol 25(3):234\u2013239","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"389_CR23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/bjc.2013.804","volume":"110","author":"M Dono","year":"2014","unstructured":"Dono M, Angelini G, Cecconi M, Amaro A, Esposito AI, Mirisola V, Maric I, Lanza F, Nasciuti F, Viaggi S, Gualco M, Bandelloni R, Truini M, Coviello DA, Zupo S, Mosci C et\u00a0al (2014) Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a\u00a0single case of uveal melanoma. Br J Cancer 110(4):1058\u20131065","journal-title":"Br J Cancer"},{"issue":"6009","key":"389_CR24","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM (2010) Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330(6009):1410\u20131413","journal-title":"Science"},{"issue":"2","key":"389_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","volume":"45","author":"JW Harbour","year":"2013","unstructured":"Harbour JW, Roberson ED, Anbunathan H, Onken MD, Worley LA, Bowcock AM (2013) Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat Genet 45(2):133\u2013135","journal-title":"Nat Genet"},{"issue":"8","key":"389_CR26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","volume":"45","author":"M Martin","year":"2013","unstructured":"Martin M, Masshofer L, Temming P, Rahmann S, Metz C, Bornfeld N, van de Nes J, Klein-Hitpass L, Hinnebusch AG, Horsthemke B, Lohmann DR, Zeschnigk M (2013) Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet 45(8):933\u2013936","journal-title":"Nat Genet"},{"issue":"2","key":"389_CR27","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O et\u00a0al (2017) Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell 32(2):204. \n                        https:\/\/doi.org\/10.1016\/j.ccell.2017.07.003","journal-title":"Cancer Cell"},{"issue":"7229","key":"389_CR28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Raamsdonk Van","year":"2009","unstructured":"Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O\u2019Brien JM, Simpson EM, Barsh GS, Bastian BC (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457(7229):599\u2013602","journal-title":"Nature"},{"issue":"23","key":"389_CR29","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Raamsdonk Van","year":"2010","unstructured":"Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R et\u00a0al (2010) Mutations in GNA11 in uveal melanoma. N\u00a0Engl J Med 363(23):2191\u20132199","journal-title":"N Engl J Med"},{"issue":"9","key":"389_CR30","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1167\/iovs.17-21838","volume":"58","author":"SL Scholz","year":"2017","unstructured":"Scholz SL, Moller I, Reis H, Susskind D, van de Nes JAP, Leonardelli S, Schilling B, Livingstone E, Schimming T, Paschen A, Sucker A, Murali R, Steuhl KP, Schadendorf D, Westekemper H, Griewank KG (2017) Frequent GNAQ, GNA11, and EIF1AX mutations in Iris melanoma. Invest Ophthalmol Vis Sci 58(9):3464\u20133470","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"389_CR31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bjophthalmol-2013-303291","volume":"97","author":"HS Mudhar","year":"2013","unstructured":"Mudhar HS, Doherty R, Salawu A, Sisley K, Rennie IG (2013) Immunohistochemical and molecular pathology of ocular uveal melanocytoma: evidence for somatic GNAQ mutations. Br J Ophthalmol 97(7):924\u2013928","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"389_CR32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/bjc.2017.259","volume":"117","author":"MJC Vader","year":"2017","unstructured":"Vader MJC, Madigan MC, Versluis M, Suleiman HM, Gezgin G, Gruis NA, Out-Luiting JJ, Bergman W, Verdijk RM, Jager MJ, van der Velden PA (2017) GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi. Br J Cancer 117(6):884\u2013887","journal-title":"Br J Cancer"},{"issue":"2","key":"389_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/pcmr.12304","volume":"28","author":"JJ Luke","year":"2015","unstructured":"Luke JJ, Triozzi PL, McKenna KC, Van Meir EG, Gershenwald JE, Bastian BC, Gutkind JS, Bowcock AM, Streicher HZ, Patel PM, Sato T, Sossman JA, Sznol M, Welch J, Thurin M, Selig S et\u00a0al (2015) Biology of advanced uveal melanoma and next steps for clinical therapeutics. Pigment Cell Melanoma Res 28(2):135\u2013147","journal-title":"Pigment Cell Melanoma Res"},{"issue":"6","key":"389_CR34","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ccr.2014.04.016","volume":"25","author":"X Feng","year":"2014","unstructured":"Feng X, Degese MS, Iglesias-Bartolome R, Vaque JP, Molinolo AA, Rodrigues M, Zaidi MR, Ksander BR, Merlino G, Sodhi A, Chen Q, Gutkind JS (2014) Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a\u00a0trio-regulated rho GTPase signaling circuitry. Cancer Cell 25(6):831\u2013845","journal-title":"Cancer Cell"},{"issue":"6","key":"389_CR35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2014.04.017","volume":"25","author":"FX Yu","year":"2014","unstructured":"Yu FX, Luo J, Mo JS, Liu G, Kim YC, Meng Z, Zhao L, Peyman G, Ouyang H, Jiang W, Zhao J, Chen X, Zhang L, Wang CY, Bastian BC, Zhang K et\u00a0al (2014) Mutant Gq\/11 promote uveal melanoma tumorigenesis by activating YAP. Cancer Cell 25(6):822\u2013830","journal-title":"Cancer Cell"},{"issue":"7","key":"389_CR36","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/bjc.2014.417","volume":"111","author":"H Kalirai","year":"2014","unstructured":"Kalirai H, Dodson A, Faqir S, Damato BE, Coupland SE (2014) Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Br J Cancer 111(7):1373\u20131380","journal-title":"Br J Cancer"},{"issue":"10","key":"389_CR37","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/modpathol.2014.43","volume":"27","author":"AE Koopmans","year":"2014","unstructured":"Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, Kockx CE, Paridaens D, Naus NC, Nellist M, van Ijcken WF, Kilic E, de Klein A (2014) Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 27(10):1321\u20131330","journal-title":"Mod Pathol"},{"issue":"2","key":"389_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/modpathol.2013.138","volume":"27","author":"KG Griewank","year":"2014","unstructured":"Griewank KG, van de Nes J, Schilling B, Moll I, Sucker A, Kakavand H, Haydu LE, Asher M, Zimmer L, Hillen U, Thompson JF, Scolyer RA, Schadendorf D, Murali R (2014) Genetic and clinico-pathologic analysis of metastatic uveal melanoma. Mod Pathol 27(2):175\u2013183","journal-title":"Mod Pathol"},{"issue":"2","key":"389_CR39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","volume":"18","author":"S Landreville","year":"2012","unstructured":"Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, Bowcock AM, Harbour JW (2012) Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res 18(2):408\u2013416","journal-title":"Clin Cancer Res"},{"issue":"12","key":"389_CR40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH (2011) Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J\u00a0Med Genet 48(12):856\u2013859","journal-title":"J Med Genet"},{"issue":"10","key":"389_CR41","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M et\u00a0al (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43(10):1022\u20131025","journal-title":"Nat Genet"},{"issue":"10","key":"389_CR42","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L, Turajlic S, Piperno-Neumann S, de la Grange P, Roman-Roman S, Stern MH, Marais R (2013) SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov 3(10):1122\u20131129","journal-title":"Cancer Discov"},{"issue":"12","key":"389_CR43","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1158\/1078-0432.CCR-07-5144","volume":"14","author":"MD Onken","year":"2008","unstructured":"Onken MD, Worley LA, Harbour JW (2008) A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res 14(12):3737\u20133745","journal-title":"Clin Cancer Res"},{"issue":"10","key":"389_CR44","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1158\/1078-0432.CCR-04-1941","volume":"11","author":"JP Ehlers","year":"2005","unstructured":"Ehlers JP, Worley L, Onken MD, Harbour JW (2005) DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res 11(10):3609\u20133613","journal-title":"Clin Cancer Res"},{"issue":"3","key":"389_CR45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1158\/0008-5472.CAN-10-0605","volume":"71","author":"C Laurent","year":"2011","unstructured":"Laurent C, Valet F, Planque N, Silveri L, Maacha S, Anezo O, Hupe P, Plancher C, Reyes C, Albaud B, Rapinat A, Gentien D, Couturier J, Sastre-Garau X, Desjardins L, Thiery JP et al (2011) High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients. Cancer Res 71(3):666\u2013674","journal-title":"Cancer Res"},{"issue":"4","key":"389_CR46","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.18632\/oncotarget.6614","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson P, Aoude LG, Wadt K, Glasson WJ, Warrier SK, Hewitt AW, Kiilgaard JF, Heegaard S, Isaacs T, Franchina M, Ingvar C, Vermeulen T, Whitehead KJ, Schmidt CW, Palmer JM, Symmons J et\u00a0al (2016) Deep sequencing of uveal melanoma identifies a\u00a0recurrent mutation in PLCB4. Oncotarget 7(4):4624\u20134631","journal-title":"Oncotarget"},{"issue":"6","key":"389_CR47","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ng.3549","volume":"48","author":"AR Moore","year":"2016","unstructured":"Moore AR, Ceraudo E, Sher JJ, Guan Y, Shoushtari AN, Chang MT, Zhang JQ, Walczak EG, Kazmi MA, Taylor BS, Huber T, Chi P, Sakmar TP, Chen Y (2016) Recurrent activating mutations of G\u2011protein-coupled receptor CYSLTR2 in uveal melanoma. Nat Genet 48(6):675\u2013680","journal-title":"Nat Genet"},{"issue":"1","key":"389_CR48","first-page":"60","volume":"29","author":"Y Krishna","year":"2017","unstructured":"Krishna Y, McCarthy C, Kalirai H, Coupland SE (2017) Inflammatory cell infiltrates in advanced metastatic uveal melanoma. Hum Pathol 29(1):60\u201367","journal-title":"Hum Pathol"},{"issue":"6","key":"389_CR49","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1167\/iovs.08-2296","volume":"50","author":"J Trolet","year":"2009","unstructured":"Trolet J, Hupe P, Huon I, Lebigot I, Decraene C, Delattre O, Sastre-Garau X, Saule S, Thiery JP, Plancher C, Asselain B, Desjardins L, Mariani P, Piperno-Neumann S, Barillot E, Couturier J (2009) Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases. Invest Ophthalmol Vis Sci 50(6):2572\u20132580","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"389_CR50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pcmr.12433","volume":"29","author":"C McCarthy","year":"2016","unstructured":"McCarthy C, Kalirai H, Lake SL, Dodson A, Damato BE, Coupland SE (2016) Insights into genetic alterations of liver metastases from uveal melanoma. Pigment Cell Melanoma Res 29(1):60\u201367","journal-title":"Pigment Cell Melanoma Res"},{"issue":"11","key":"389_CR51","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1167\/iovs.07-0215","volume":"48","author":"T Meir","year":"2007","unstructured":"Meir T, Dror R, Yu X, Qian J, Simon I, Pe\u2019er J, Chowers I (2007) Molecular characteristics of liver metastases from uveal melanoma. Invest Ophthalmol Vis Sci 48(11):4890\u20134896","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"389_CR52","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/eye.2012.254","volume":"27","author":"N Kenawy","year":"2013","unstructured":"Kenawy N, Lake SL, Coupland SE, Damato BE (2013) Conjunctival melanoma and melanocytic intra-epithelial neoplasia. Eye (Lond) 27(2):142\u2013152","journal-title":"Eye (Lond)"},{"issue":"11","key":"389_CR53","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/bjo.2009.157933","volume":"93","author":"E Triay","year":"2009","unstructured":"Triay E, Bergman L, Nilsson B, All-Ericsson C, Seregard S (2009) Time trends in the incidence of conjunctival melanoma in Sweden. Br J Ophthalmol 93(11):1524\u20131528","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"389_CR54","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1442-9071.2008.01888.x","volume":"36","author":"B Damato","year":"2008","unstructured":"Damato B, Coupland SE (2008) Conjunctival melanoma and melanosis: a\u00a0reappraisal of terminology, classification and staging. J\u00a0Clin Exp Ophthalmol 36(8):786\u2013795","journal-title":"J Clin Exp Ophthalmol"},{"issue":"9","key":"389_CR55","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1586\/era.09.85","volume":"9","author":"B Damato","year":"2009","unstructured":"Damato B, Coupland SE (2009) Management of conjunctival melanoma. Expert Rev Anticancer Ther 9(9):1227\u20131239","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"389_CR56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archophthalmol.2009.394","volume":"128","author":"FA Jakobiec","year":"2010","unstructured":"Jakobiec FA, Bhat P, Colby KA (2010) Immunohistochemical studies of conjunctival nevi and melanomas. Arch Ophthalmol 128(2):174\u2013183","journal-title":"Arch Ophthalmol"},{"key":"389_CR57","first-page":"64","volume":"110","author":"B Esmaeli","year":"2012","unstructured":"Esmaeli B, Roberts D, Ross M, Fellman M, Cruz H, Kim SK, Prieto VG (2012) Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis). Trans Am Ophthalmol Soc 110:64\u201373","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"389_CR58","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1111\/aos.13252","volume":"95","author":"ML Pfeiffer","year":"2017","unstructured":"Pfeiffer ML, Ozgur OK, Myers JN, Peng A, Ning J, Zafereo ME, Thakar S, Thuro B, Prieto VG, Ross MI, Esmaeli B (2017) Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmol (Copenh) 95(4):e323\u2013e328","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"4","key":"389_CR59","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ophtha.2003.11.001","volume":"111","author":"S Tuomaala","year":"2004","unstructured":"Tuomaala S, Kivela T (2004) Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy. Ophthalmology 111(4):816\u2013821","journal-title":"Ophthalmology"},{"issue":"2","key":"389_CR60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.86.2.163","volume":"86","author":"G Anastassiou","year":"2002","unstructured":"Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl KP (2002) Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a\u00a0retrospective study. Br J Ophthalmol 86(2):163\u2013167","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"389_CR61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IOP.0b013e3182611670","volume":"28","author":"CL Shields","year":"2012","unstructured":"Shields CL, Kaliki S, Al-Dahmash SA, Lally SE, Shields JA (2012) American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes. Ophthal Plast Reconstr Surg 28(5):313\u2013323","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"11","key":"389_CR62","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/02713680701648019","volume":"32","author":"S Tuomaala","year":"2007","unstructured":"Tuomaala S, Toivonen P, Al-Jamal R, Kivela T (2007) Prognostic significance of histopathology of primary conjunctival melanoma in Caucasians. Curr Eye Res 32(11):939\u2013952","journal-title":"Curr. Eye Res."},{"issue":"8","key":"389_CR63","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1167\/iovs.04-0093","volume":"45","author":"H Gear","year":"2004","unstructured":"Gear H, Williams H, Kemp EG, Roberts F (2004) BRAF mutations in conjunctival melanoma. Invest Ophthalmol Vis Sci 45(8):2484\u20132488","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"389_CR64","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1167\/iovs.04-1449","volume":"46","author":"N Goldenberg-Cohen","year":"2005","unstructured":"Goldenberg-Cohen N, Cohen Y, Rosenbaum E, Herscovici Z, Chowers I, Weinberger D, Pe\u2019er J, Sidransky D (2005) T1799A BRAF mutations in conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci 46(9):3027\u20133030","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"389_CR65","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1158\/1078-0432.CCR-13-0163","volume":"19","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Westekemper H, Murali R, Mach M, Schilling B, Wiesner T, Schimming T, Livingstone E, Sucker A, Grabellus F, Metz C, Susskind D, Hillen U, Speicher MR, Woodman SE, Steuhl KP et\u00a0al (2013) Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas. Clin Cancer Res 19(12):3143\u20133152","journal-title":"Clin Cancer Res"},{"issue":"8","key":"389_CR66","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1167\/iovs.10-6934","volume":"52","author":"SL Lake","year":"2011","unstructured":"Lake SL, Jmor F, Dopierala J, Taktak AF, Coupland SE, Damato BE (2011) Multiplex ligation-dependent probe amplification of conjunctival melanoma reveals common BRAF V600E gene mutation and gene copy number changes. Invest Ophthalmol Vis Sci 52(8):5598\u20135604","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"21","key":"389_CR67","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1158\/1078-0432.CCR-08-0575","volume":"14","author":"C Beadling","year":"2008","unstructured":"Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz F 3rd, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL (2008) KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 14(21):6821\u20136828","journal-title":"Clin Cancer Res"},{"issue":"2","key":"389_CR68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2013.312","volume":"109","author":"KG Griewank","year":"2013","unstructured":"Griewank KG, Murali R, Schilling B, Scholz S, Sucker A, Song M, Susskind D, Grabellus F, Zimmer L, Hillen U, Steuhl KP, Schadendorf D, Westekemper H, Zeschnigk M (2013) TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours. Br J Cancer 109(2):497\u2013501","journal-title":"Br J Cancer"},{"issue":"9","key":"389_CR69","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1167\/iovs.14-14901","volume":"55","author":"AE Koopmans","year":"2014","unstructured":"Koopmans AE, Ober K, Dubbink HJ, Paridaens D, Naus NC, Belunek S, Krist B, Post E, Zwarthoff EC, de Klein A, Verdijk RM (2014) Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions. Invest Ophthalmol Vis Sci 55(9):6024\u20136030","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-017-0389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-017-0389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T06:42:29Z","timestamp":1509000149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-017-0389-3"}},"subtitle":["Ein \u201eUpdate\u201c","An update"],"short-title":[],"issued":{"date-parts":[[2017,10,16]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["389"],"URL":"https:\/\/doi.org\/10.1007\/s00292-017-0389-3","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,16]]}}}